Alzheimer Disease
Alzheimer Disease is a topic covered in the Johns Hopkins Psychiatry Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
DEFINITION
- Alzheimer disease (AD) is a neurodegenerative disease and the most common cause of dementia.
- There is growing recognition of individuals with cognitive impairment at a severity level insufficient for a diagnosis of dementia. Two terms have been used to describe these individuals:
- Cognitive impairment, no dementia (CIND)
- Mild cognitive impairment (MCI)
- Cortical atrophy, amyloid-predominant neuritic plaques, tau-predominant neurofibrillary tangles, and neuronal death are hallmarks of the pathological diagnosis of AD confirmed via postmortem histopathological examination.[2]
- Cascade view of etiopathogenesis of AD[3]:
- Genetic and environmental risk factors interact to increase the production or to decrease the clearance of a toxic form of a peptide (amyloid beta (abeta) 1-42) derived from turnover of the amyloid precursor protein (APP), a transmembrane protein present on neurons.
- If APP is processed through cleavage by β-secretase preferentially over α-secretase, this leads to the formation of abeta 1-42 that is prone to dimerization, oligomerization, and deposition in the extracellular space.
- The deposited abeta 1-42 accumulates close to the synaptic cleft and is thought to lead over time to synaptic disconnection, the loss of neurotransmitter systems, and the emergence of symptoms.
- Cognitive impairment due to AD is classified under the neurocognitive disorders (NCDs) section of the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5).[2]
-- To view the remaining sections of this topic, please log in or purchase a subscription --
DEFINITION
- Alzheimer disease (AD) is a neurodegenerative disease and the most common cause of dementia.
- There is growing recognition of individuals with cognitive impairment at a severity level insufficient for a diagnosis of dementia. Two terms have been used to describe these individuals:
- Cognitive impairment, no dementia (CIND)
- Mild cognitive impairment (MCI)
- Cortical atrophy, amyloid-predominant neuritic plaques, tau-predominant neurofibrillary tangles, and neuronal death are hallmarks of the pathological diagnosis of AD confirmed via postmortem histopathological examination.[2]
- Cascade view of etiopathogenesis of AD[3]:
- Genetic and environmental risk factors interact to increase the production or to decrease the clearance of a toxic form of a peptide (amyloid beta (abeta) 1-42) derived from turnover of the amyloid precursor protein (APP), a transmembrane protein present on neurons.
- If APP is processed through cleavage by β-secretase preferentially over α-secretase, this leads to the formation of abeta 1-42 that is prone to dimerization, oligomerization, and deposition in the extracellular space.
- The deposited abeta 1-42 accumulates close to the synaptic cleft and is thought to lead over time to synaptic disconnection, the loss of neurotransmitter systems, and the emergence of symptoms.
- Cognitive impairment due to AD is classified under the neurocognitive disorders (NCDs) section of the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5).[2]
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: March 1, 2017
Citation
Peters, Matthew E, and Constantine G Lyketsos. "Alzheimer Disease." Johns Hopkins Psychiatry Guide, 2017. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787107/all/Alzheimer_Disease.
Peters ME, Lyketsos CG. Alzheimer Disease. Johns Hopkins Psychiatry Guide. 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787107/all/Alzheimer_Disease. Accessed January 26, 2023.
Peters, M. E., & Lyketsos, C. G. (2017). Alzheimer Disease. In Johns Hopkins Psychiatry Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787107/all/Alzheimer_Disease
Peters ME, Lyketsos CG. Alzheimer Disease [Internet]. In: Johns Hopkins Psychiatry Guide. ; 2017. [cited 2023 January 26]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787107/all/Alzheimer_Disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Alzheimer Disease
ID - 787107
A1 - Peters,Matthew,M.D.
AU - Lyketsos,Constantine,M.D.
Y1 - 2017/03/01/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787107/all/Alzheimer_Disease
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -